Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: Role in the regulation of aryl hydrocarbon receptor (AHR) function

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 771-780

  Tan, Zongqing ^a   Chang, Xiaoqing ^a   Puga, Alvaro ^a   Xia, Ying ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Ah receptor; AHR dependent gene transcription; CYP1A1 induction; Dioxin; MAP kinase activation; Non genomic effect

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; TUMOR PROMOTER;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BLOOD GROUP; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A1; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; HYDROCARBONS, AROMATIC; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036711207     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01138-3     Document Type: Article

References (48)

1. Zedeck M.S. Polycyclic aromatic hydrocarbons: a review. J. Environ. Pathol. Toxicol. 3:1980;537-567.
2. Hahn M.E. The aryl hydrocarbon receptor: a comparative perspective. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 121:1998;23-53.
3. Whitlock J.P. Jr. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:1999;103-125.
4. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140:1996;173-179.
5. Park R., Kim D.H., Kim M.S., So H.S., Chung H.T., Kwon K.B., Ryu D.G., Kim B.R. Association of Shc, Cb1, Grb2, and Sos following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary rat hepatocytes. Biochem. Biophys. Res. Commun. 253:1998;577-581.
6. Bombick D.W., Matsumura F. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes an increase in protein tyrosine kinase activities at an early stage of poisoning in vivo in rat hepatocyte membranes. Life Sci. 41:1987;429-436.
7. Enan E., Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem. Pharmacol. 52:1996;1599-1612.
8. el-Sabeawy F., Wang S., Overstreet J., Miller M., Lasley B., Enan E. Treatment of rats during pubertal development with 2,3,7,8-tetrachlorodibenzo-p-dioxin alters both signaling kinase activities and epidermal growth factor receptor binding in the testis and the motility and acrosomal reaction of sperm. Toxicol. Appl. Pharmacol. 150:1998;427-442.
9. Hossain A.et al. The Ah receptor is not involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in human leukemic T cell lines. J. Biol. Chem. 273:1998;19853-19858.
10. Davis R.J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42:1995;459-467.
11. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell. Biol. 9:1997;240-246.
12. Puga A., Nebert D.W., Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell. Biol. 11:1992;269-281.
13. Hoffer A., Chang C.Y., Puga A. Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol. Appl. Pharmacol. 141:1996;238-247.
14. Ashida H., Nagy S., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in activities of nuclear protein kinases and phosphatases affecting DNA binding activity of c-Myc and AP-1 in the livers of guinea pigs. Biochem. Pharmacol. 59:2000;741-751.
15. Lee P.J., Camhi S.L., Chin B.Y., Alam J., Choi A.M. AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:2000;L175-L182.
16. Carrier F., Owens R.A., Nebert D.W., Puga A. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell. Biol. 12:1992;1856-1863.
17. Park S., Henry E.C., Gasiewicz T.A. Regulation of DNA binding activity of the ligand-activated aryl hydrocarbon receptor by tyrosine phosphorylation. Arch. Biochem. Biophys. 381:2000;302-312.
18. Pongratz I., Stromstedt P.F., Mason G.G., Poellinger L. Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J. Biol. Chem. 266:1991;16813-16817.
19. Chang C.Y., Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol. Cell. Biol. 18:1998;525-535.
20. Liang Q., Wiese R.J., Bueno O.F., Dai Y.S., Markham B.E., Molkentin J.D. The transcription factor gata4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol. Cell. Biol. 21:2001;7460-7469.
21. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
22. Puga A., Barnes S.J., Dalton T.P., Chang C., Knudsen E.S., Maier M.A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem. 275:2000;2943-2950.
23. Crews C.M., Alessandrini A., Erikson R.L. Erks: their fifteen minutes has arrived. Cell Growth Differ. 3:1992;135-142.
24. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
25. Kano I., Gielen J.E., Yagi H., Jerina D.M., Nebert D.W. Subcellular events occurring during aryl hydrocarbon hydroxylase induction: no requirement for metabolism of polycyclic hydrocarbon inducer. Mol. Pharmacol. 13:1997;1181-1186.
26. Bigelow S.W., Nebert D.W. The Ah regulatory gene product Survey of nineteen polycyclic aromatic compounds' and fifteen benzo[a]pyrene metabolites' capacity to bind to the cytosolic receptor. Toxicol. Lett. 10:1982;109-118.
27. Favata M.F.et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
28. Ajizian S.J., English B.K., Meals E.A. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J. Infect. Dis. 179:1999;939-944.
29. Reiners J.J. Jr., Lee J.Y., Clift R.E., Dudley D.T., Myrand S.P. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol. Pharmacol. 53:1998;438-445.
30. Delescluse C., Lemaire G., de Sousa G., Rahmani R. Is CYP1A1 induction always related to AHR signaling pathway? Toxicology. 153:2000;73-82.
31. Lenormand P., Pages G., Sardet C., L'Allemain G., Meloche S., Pouyssegur J. MAP kinases: activation, subcellular localization and role in the control of cell proliferation. Adv. Second Messenger Phosphoprotein Res. 28:1993;237-244.
32. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1999;1358-1362.
33. Faux M.C., Scott J.D. Molecular glue: kinase anchoring and scaffold proteins. Cell. 85:1996;9-12.
34. Okino S.T., Pendurthi U.R., Tukey R.H. Phorbol esters inhibit the dioxin receptor-mediated transcriptional activation of the mouse Cyp1a-1 and Cyp1a-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 267:1992;6991-6998.
35. Wade C.B., Robinson S., Shapiro R.A., Dorsa D.M. Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology. 142:2001;2336-2342.
36. Kato S.et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
37. Kato S. Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer. 8:2001;3-9.
38. Li S.Y., Dougherty J.J. Inhibitors of serine/threonine-specific protein phosphatases stimulate transcription by the Ah receptor/ARNT dimer by affecting a step subsequent to XRE binding. Arch. Biochem. Biophys. 340:1997;73-82.
39. Madhukar B.V., Ebner K., Matsumura F., Bombick D.W., Brewster D.W., Kawamoto T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an increase in protein kinases associated with epidermal growth factor receptor in the hepatic plasma membrane. J. Biochem. Toxicol. 3:1988;261-277.
40. Sewall C.H., Lucier G.W., Tritscher A.M., Clark G.C. TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD. Carcinogenesis. 14:1993;1885-1893.
41. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
42. Rosette C., Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 274:1996;1194-1197.
43. Puga A., Hoffer A., Zhou S., Bohm J.M., Leikauf G.D., Shertzer H.G. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem. Pharmacol. 54:1997;1287-1296.
44. Legare M.E., Hanneman W.H., Barhoumi R., Tiffany-Castiglioni E. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in primary rat astroglia: identification of biochemical and cellular targets. Neurotoxicology. 18:1997;515-524.
45. Doherty P., Williams G., Williams E.J. CAMs and axonal growth: a critical evaluation of the role of calcium and the MAPK cascade. Mol. Cell. Neurosci. 16:2000;283-295.
46. 2+ in the MCF-10A human mammary epithelial cell line by carcinogenic polycyclic aromatic hydrocarbons. Mol. Carcinog. 25:1999;48-54.
47. Guo M., Joiakim A., Dudley D.T., Reiners J.J. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated CYP1A1 and CYP1B1 induction by 12-O-tetradecanoylphorbol-13-acetate: role of transforming growth factor beta and mitogen-activated protein kinases. Biochem. Pharmacol. 62:2001;1449-1457.
48. Cowley S., Paterson H., Kemp P., Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.